Literature DB >> 25639751

Famine versus feast: understanding the metabolism of tumors in vivo.

Jared R Mayers1, Matthew G Vander Heiden2.   

Abstract

To fuel unregulated proliferation, cancer cells alter metabolism to support macromolecule biosynthesis. Cell culture studies have revealed how different oncogenic mutations and nutrients impact metabolism. Glucose and glutamine are the primary fuels used in vitro; however, recent studies have suggested that utilization of other amino acids as well as lipids and protein can also be important to cancer cells. Early investigations of tumor metabolism are translating these findings to the biology of whole tumors and suggest that additional complexity exists beyond nutrient availability alone in vivo. Whole-body metabolism and tumor heterogeneity also influence the metabolism of tumor cells, and successful targeting of metabolism for cancer therapy will require an understanding of tumor metabolism in vivo.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer metabolism; cell proliferation; nutrient availability; tumor metabolism

Mesh:

Substances:

Year:  2015        PMID: 25639751      PMCID: PMC4340757          DOI: 10.1016/j.tibs.2015.01.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  110 in total

1.  The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.

Authors:  Min Fang; Zhirong Shen; Song Huang; Liping Zhao; She Chen; Tak W Mak; Xiaodong Wang
Journal:  Cell       Date:  2010-11-11       Impact factor: 41.582

Review 2.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

3.  Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.

Authors:  J Khasawneh; M D Schulz; A Walch; J Rozman; M Hrabe de Angelis; M Klingenspor; A Buck; M Schwaiger; D Saur; R M Schmid; G Klöppel; B Sipos; F R Greten; M C Arkan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

4.  Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.

Authors:  Jason W Locasale; Alexandra R Grassian; Tamar Melman; Costas A Lyssiotis; Katherine R Mattaini; Adam J Bass; Gregory Heffron; Christian M Metallo; Taru Muranen; Hadar Sharfi; Atsuo T Sasaki; Dimitrios Anastasiou; Edouard Mullarky; Natalie I Vokes; Mika Sasaki; Rameen Beroukhim; Gregory Stephanopoulos; Azra H Ligon; Matthew Meyerson; Andrea L Richardson; Lynda Chin; Gerhard Wagner; John M Asara; Joan S Brugge; Lewis C Cantley; Matthew G Vander Heiden
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

5.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

6.  Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells.

Authors:  L G Boros; J S Torday; S Lim; S Bassilian; M Cascante; W N Lee
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

8.  Altered leucine metabolism in noncachectic sarcoma patients.

Authors:  R I Inculet; T P Stein; J L Peacock; M Leskiw; M Maher; C M Gorschboth; J A Norton
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  81 in total

Review 1.  T cell metabolic reprogramming and plasticity.

Authors:  Maria Slack; Tingting Wang; Ruoning Wang
Journal:  Mol Immunol       Date:  2015-08-12       Impact factor: 4.407

Review 2.  Amino acid management in cancer.

Authors:  Zhi-Yang Tsun; Richard Possemato
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

Review 3.  Imaging Adenosine Triphosphate (ATP).

Authors:  Megha Rajendran; Eric Dane; Jason Conley; Mathew Tantama
Journal:  Biol Bull       Date:  2016-08       Impact factor: 1.818

Review 4.  Pancreatic cancer from bench to bedside: molecular pathways and treatment options.

Authors:  Christoforos Kosmidis; Konstantinos Sapalidis; Efstathios Kotidis; Nikolaos Mixalopoulos; Paul Zarogoulidis; Drosos Tsavlis; Sofia Baka; Yan-Gao Man; John Kanellos
Journal:  Ann Transl Med       Date:  2016-05

Review 5.  Pheochromocytoma: The First Metabolic Endocrine Cancer.

Authors:  Ivana Jochmanova; Karel Pacak
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

6.  Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.

Authors:  Irfana Soomro; Ying Sun; Zhai Li; Lonnette Diggs; Georgia Hatzivassiliou; Ajit G Thomas; Rana Rais; Seth J Parker; Barbara S Slusher; Alec C Kimmelman; Stefan Somlo; Edward Y Skolnik
Journal:  Nephrol Dial Transplant       Date:  2018-08-01       Impact factor: 5.992

Review 7.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

8.  miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.

Authors:  Bruna Rodrigues Muys; Josane F Sousa; Jessica Rodrigues Plaça; Luíza Ferreira de Araújo; Aishe A Sarshad; Dimitrios G Anastasakis; Xiantao Wang; Xiao Ling Li; Greice Andreotti de Molfetta; Anelisa Ramão; Ashish Lal; Daniel Onofre Vidal; Markus Hafner; Wilson A Silva
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

Review 9.  Biochemical Underpinnings of Immune Cell Metabolic Phenotypes.

Authors:  Benjamin A Olenchock; Jeffrey C Rathmell; Matthew G Vander Heiden
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

10.  mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1.

Authors:  Joseph G Moloughney; Peter K Kim; Nicole M Vega-Cotto; Chang-Chih Wu; Sisi Zhang; Matthew Adlam; Thomas Lynch; Po-Chien Chou; Joshua D Rabinowitz; Guy Werlen; Estela Jacinto
Journal:  Mol Cell       Date:  2016-08-25       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.